Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

The ability to compare the volumes of patients’ brain structures to brain structure volumes of healthy controls is a powerful tool to help physicians assess possible existence of neurodegeneration or the progression of a neurodegenerative disorder.

To adjust for any variation in brain size, sex difference, and inter-individual head-size in a population, brain structure volumes are normalized (or scaled) to a common measurement.

Cortechs.ai’ quantitative imaging software uses Intracranial Volume (ICV) to normalize an individual’s brain structure volumes, and automatically calculates it during the post-processing of brain MRIs for volumetric analysis. This consistent measure gives clinicians additional context of their patient’s brain structure volumes, regardless of head size.

ICV, also known as TIV (Total Intracranial Volume), is the volume of the cranial cavity as taken from a 3D T1 MRI, as outlined by the supratentorial dura matter, or cerebral contour when dura is not clearly detectable.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products
Example of segmentation with intracranial mask from T1-weighted image. Image credit: Malone, I.B. et al. (2015). Accurate Automatic Estimation of Total Intracranial Volume: A Nuisance Variable with Less Nuisance. NeuroImage 104 (366-372).

ICV is a very consistent measure across the lifespan of a patient, making it a reliable tool for correction of head size variation across individuals. This correction is especially helpful when assessing neurodegenerative conditions.

For example, Patient A and Patient B both have thalamic volumes that are consistent with the average for their age and sex-matched population. Patient A is 5’6” tall, with an average head circumference, while Patient B is 6’2” tall with an above average head circumference. If the thalamic volumes could be interpreted without correcting for ICV, both patients would yield a normal result. However, once the patient’s thalamic volumes are normalized to their individual ICV, it could become apparent that Patient B’s thalamic volume is lower than expected for their age and gender.

NeuroQuant reports provide brain structure volumes (relevant to the report), % ICV and normative percentiles. NeuroQuant automatically calculates the ICV to accurately compare an individual’s brain structure volumes to Cortechs.ai’ age and sex-matched normative reference data. The ICV normalization and reference comparison on NeuroQuant reports provide physicians with a framework to better understand brain structure volumes when assessing patients.

Cortechs.ai | Understanding Intracranial Volume (ICV) Analysis in Cortechs.ai’ Quantitative Imaging Products

Need more information about ICV or Cortechs.ai quantitative image products? Contact us.

 

More Resources

04/22/2025

Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America

Cortechs.ai receives Health Canada approval to expand its AI imaging solutions into Canada, advancing diagnostic precision and patient care.

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.

03/27/2025

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

We are pleased to announce a strategic partnership with Kryptonite Solutions to distribute our innovative portfolio across India.

03/20/2025

Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East

We are pleased to announce a strategic distribution partnership with Medical Horizons, a premier AI-powered medical device distributor based in Florence, Italy.

03/18/2025

Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring

Unlock the power of AI-driven imaging with NeuroQuant® MS—enhancing lesion detection, monitoring, and personalized care for Multiple Sclerosis.
Scroll to Top